维普中文期刊产品整合服务
14篇 您的检索式:作者名="Chouaki"
    题名 作者 年代 出处 被引量
1Muon flux measurement at China Jinping Underground Laboratory显示文摘China Jinping Underground Laboratory(CJPL)is ideal for studying solar,geo-,and supernova neutrinos.A precise measurement of the cosmic-ray background is essential in proceeding with R&D research for these MeV-scale neutrino experiments.Using a 1-ton prototype detector for the Jinping Neutrino Experiment(JNE),we detected 264 high-energy muon events from a 645.2-day dataset from the first phase of CJPL(CJPL-I),reconstructed their directions,and measured the cosmic-ray muon flux to be (3.53±0.22_stat.±0.07_sys.)×-10^(-10)cm^(-2).The observed angular distributions indicate the leakage of cosmic-ray muon background and agree with simulation data accounting for Jinping mountain's terrain.A survey of muon fluxes at different laboratory locations,considering both those situated under mountains and those down mine shafts,indicates that the flux at the former is generally a factor of (4±2) larger than at the latter,with the same vertical overburden.This study provides a convenient back-of-the-envelope estimation for the muon flux of an underground experiment.郭子溢 Lars Bathe-Peters 陈少敏 Mourad Chouaki 窦威 郭磊 Ghulam Hussain 李进京 刘倩 罗光 骆文泰 祁鸣 邵文辉 唐健 万林焱 王喆 续本达 徐彤 徐蔚然 杨玉梓 Minfang Yeh 赵林 2021Chinese Physics C2021,45,2:2
2Otitis Externa due to Trichoderma longibrachiatum显示文摘C. Hennequin T. Chouaki J. C. Pichon V. Strunski C. Raccurt 2000European Journal of Clinical Microbiology and Infections Diseases2000,,8:1
3A phase Ⅱ study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck显示文摘 Chouaki N Leyvraz S 1999Br J Cancer1999,81,:1
4Survival without commontoxicity criteria grade 3/4toxicity for pemetrexed compared withdocetaxel in previously treated patients with advanced non-smallcell lung cancer(NSCLC):a risk-benefit analysis显示文摘Pujol JL Paul S Chouaki N 2007J ThoracOncol2007,2,5:1
5Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type显示文摘A. Hasbini R. Mahjoubi A. Fandi N. Chouaki A. Taamma P. Lianes H. Cortès-funes S. Alonso J. P. Armand E. Cvitkovic E. Raymond 1999Annals of Oncology1999,,4:1
6Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC) : a risk-benefit analysis显示文摘Pujol JL Paul S Chouaki N 2007J Thorac Oncol2007,2,5:1
7Survival without common t oxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer(NSCLC):a risk2 benefit analysis显示文摘Pujol JL Paul S Chouaki N 2007J Thorac Oncol2007,2,5:1
8PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer显示文摘Luis G. Paz-Ares Filippo de Marinis Mircea Dediu Michael Thomas Jean-Louis Pujol Paolo Bidoli Olivier Molinier Tarini Prasad Sahoo Eckart Laack Martin Reck Jesús Corral Symantha Melemed William John Nadia Chouaki Annamaria H. Zimmermann Carla Visseren-Gru 2013Journal of Clinical Oncology2013,,23:1
9Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis 显示文摘Pujol JL Paul S Chouaki N 2007J Thorac Oncol2007,2,5:1
10Application of a posteriori error estimation for structural model updating显示文摘Lndeveze P Chouaki A 1999Inverse Problems1999,15,:1
11Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, random显示文摘Luis Paz-Ares Filippo de Marinis Mircea Dediu Michael Thomas Jean-Louis Pujol Paolo Bidoli Olivier Molinier Tarini Prasad Sahoo Eckart Laack Martin Reck Jesús Corral Symantha Melemed William John Nadia Chouaki Annamaria H Zimmermann Carla Visseren-Grul Ce 2012Lancet Oncology2012,,3:1
12Survival without common toxic-ity criteria grade 3/4 toxicity for pemetrexed compared with docetax-el in previously treated patients with advanced non2s mall cell lungcancer ( NSCLC ) : a risk-benefit analysis 显示文摘Pujol JL Paul S Chouaki N 2007J Thorac Oncol2007,2,5:1
13Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC) : a risk benefit analysis显示文摘Pujol JL Paul S Chouaki N 2007J Thorac Oncol2007,2,5:1
14Measurement of muon-induced neutron yield at the China Jinping Underground Laboratory显示文摘Solar,terrestrial,and supernova neutrino experiments are subject to muon-induced radioactive background.The China Jinping Underground Laboratory(CJPL),with its unique advantage of a 2400 m rock coverage and long distance from nuclear power plants,is ideal for MeV-scale neutrino experiments.Using a 1-ton prototype detector of the Jinping Neutrino Experiment(JNE),we detected 3 43 high-energy cosmic-ray muons and(7.86±3.97)muon-induced neutrons from an 820.28-day dataset at the first phase of CJPL(CJPL-I).Based on the muon-induced neutrons,we measured the corresponding muon-induced neutron yield in a liquid scintillator to be(3.44±1.86_(stat.)±0.76_(syst.))×10^(-4) μ^(-1)g^(-1)cm^(2) at an average muon energy of 340 GeV.We provided the first study for such neutron background at CJPL.A global fit including this measurement shows a power-law coefficient of(0.75±0.02) for the dependence of the neutron yield at the liquid scintillator on muon energy.赵林 骆文泰 Lars Bathe-Peters 陈少敏 Mourad Chouaki 窦威 郭磊 郭子溢 Ghulam Hussain 李进京 梁晔 刘倩 罗光 祁鸣 邵文辉 唐健 万林焱 王喆 武益阳 续本达 徐彤 徐蔚然 杨玉梓 Minfang Yeh 张爱强 张彬 JNE collaboration 2022Chinese Physics C2022,46,8:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费